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Central to the development of a catabolic state after surgical trauma is the onset of a 
temporary loss of tissue sensitivity to circulating levels of insulin, the most powerful 
anabolic hormone 1. During the last decades, development of acute insulin resistance and 
concomitant hyperglycaemia after surgery has been identified as an independent negative 
predictor of outcome 2 and hospital stay 3, regardless the preoperative diabetic state of the 
patient. The primary site of insulin resistance after surgery is skeletal muscle in which 
both non-oxidative and oxidative glucose disposal becomes inhibited 4,5. The degree and 
duration of postoperative insulin resistance is related to the extent of the surgical 
procedure 3 and postoperative stress-hormone concentrations, especially cortisol 6, but 
also to the systemic inflammatory response 6,7. Previous research suggests that during and 
after surgery cross-talk between pro-inflammatory cytokines and muscle insulin 
signalling exists 8,9. The cellular pathophysiological alterations seem to bear close 
resemblance to those seen in chronic insulin resistant states, such as metabolic syndrome 
and diabetes mellitus type 2, which are associated with chronic low-grade inflammation 
10, mitochondrial dysfunction and increased production of reactive oxygen species 11, but 
the underlying mechanisms are still not fully understood. 
Development of peripheral postoperative insulin resistance can be reduced by   
administration of a carbohydrate rich beverage prior to surgery instead of overnight 
fasting. This simple preoperative intervention has been shown to improve postoperative 
oxidative glucose disposal 12,13 and shorten hospital stay after major abdominal surgery 
14. Furthermore, in a recent study investigating the adherence level to the advanced 
recovery after surgery (ERAS) protocol in colorectal surgery patients, preoperative 
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carbohydrate treatment was identified as a major independent contributor to reduced risk 
of postoperative nausea and vomiting, pain, diarrhoea, dizziness and wound dehiscence 
15.  
The established routine of preoperative carbohydrate supplementation consists of  
a large dose of 100 g in the evening and a smaller dose of 50 g up to two hours prior to 
surgery and is recommended (grade of recommendation A) as part of the preoperative 
metabolic care of most surgical patients 16. However, the necessity of a preoperative 
evening dose has been questioned, as modern guidelines allow patients to eat until 6 
hours prior to surgery 17,18 and previous research has indicated a predominant effect of the 
dose given immediately before surgery 19. 
Lastly, the mechanisms underlying the effect of preoperative carbohydrate  
supplementation are still unclear, although interestingly, recent evidence suggests that 
modulation of the inflammatory response to surgery plays a key role in maintaining 
postoperative insulin sensitivity 20. 
Thus, the present work was initiated to investigate the cellular mechanisms that  
underlie the development of postoperative insulin resistance and the prophylactic effect 










5.1. Metabolic alterations in response to injury 
In a phylogenetic perspective, metabolic changes to major injury are part of a well 
preserved physiologic response which purpose is to increase the chance of survival. The 
priority-setting of whole body substrate and nutrient distribution changes in the aftermath 
of physical trauma, with the potential of subsequent infection and inability to provide 
food. Enhanced protein breakdown in skeletal muscle is followed by redistribution of 
amino acids to provide for hepatic acute phase protein synthesis and gluconeogenesis, 
proliferation and vital functions of sanatory immunocompetent cells and enterocytes 
together with endothelial integrity and protein synthesis in the healing wound 21,22. 
Lipolysis and the overall oxidation rate of fat and ketone bodies increase as they take 
over as primary fuels to cover energy expenditure in the liver, kidney, heart and skeletal 
muscle 23-25. Concurrently, peripheral glucose uptake and disposal is impaired 24,26 and 
available glucose is shunted to glucose dependent cells and tissues such as red and white 
blood cells, neurons, wound tissue and the renal medulla.  
Stress-related alterations to the homeostatic internal environment in man were  
anticipated already by the ancient Greek natural philosophers 27. Sir David Cuthbertson 
was the first to describe in detail the metabolic alterations following injury during his 
pioneer work in the 1930`s 28. Based on animal experiments and measurements on 
patients with accidental lower limb injuries he introduced the terms ‘ebb’ and ‘flow’ in an 
attempt to create a chronological description of post-injury metabolic responses. The 
initial ‘ebb’ phase was characterized by tissue hypoperfusion, peripheral vasoconstriction 
and decreased metabolic activity during the first hours after injury. Within 24 hours the 
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ebb phase was normally followed by a hypermetabolic state, called the ‘flow’ phase, 
characterized by breakdown of body tissues and increased metabolic rate. His findings of 
an acute reduction in metabolic rate during ‘ebb’ probably was influenced by small 
animal research on severe injury and haemorrhage with circulatory hypovolemia, and the 
increment in metabolic rate during ‘flow’ is much less than originally believed 29, and do 
not reflect the actual metabolic changes seen after modern elective surgery accompanied 
by multimodal stress-reducing approaches 30,31. However, his subdivision of two post 
injury phases of metabolic change on the basis of metabolic rate prevails, influences 
research on the field and is still quoted.  
 
5.2. Acute insulin resistance and diabetes of injury 
Acute changes in carbohydrate metabolism were first scientifically reported during the 
late 19th century with the observation of glycosuria following ether anaesthesia by 
Reynoso in 1853 32. His findings were supported by the French physiologist Claude 
Bernards experiments in 1877 33 in which he demonstrated acute hyperglycaemia after 
haemorrhagic shock and later by Weddell in 1934 34 who reported hyperglycaemia during 
and after surgery. Since then the terms “stress diabetes” and “diabetes of injury” have 
been used to describe the phenomenon of acute trauma induced insulin resistance and 
hyperglycaemia, the cardinal feature of stress metabolism.  
In an otherwise healthy individual exposed to major trauma, fat and amino acids  
are available in great abundance. On the other hand, due to the need for solution in water 
and electrolytes to maintain an isotonic environment 35, glucose is stored of relatively 
limited quantity as glycogen in skeletal muscle (~400 grams) and liver (~100 grams) 36. 
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The role of acute insulin resistance in the complex metabolic response to trauma seems to 
be multifaceted. For one thing, augmentation of hepatic glucose output and reduced 
utilisation of glucose in skeletal muscle increases the total glucose pool. Concurrently, 
the liver and musculature converts from glucose to fat oxidation, which reduces total 
glucose consumption. Available glucose is shunted to glucose dependent tissues through 
non-insulin dependent glucose uptake. In the early phase after physical trauma, acute 
insulin resistance thereby also reduces protein catabolism as the need for gluconeogenic 
precursors is reduced. I addition increased blood sugar concentration serves as a 
significant osmotic force which counteracts haemorrhagic hypovolemia and shock 37. In a 
phylogenetic perspective these alterations in nutrient and substrate distribution are 
probably meant to support survival of the organism after injury within a period of the first 
few hours and days, after which a state of convalescence is reached or the individual dies.  
On the other hand, in a modern clinical setting with sterile elective surgery, antibiotic 
treatment and advanced postoperative care, including fluid and nutrient substitution, it 
seems that these ancient adaptive physiologic responses to trauma has turned out to be  
negative with regard to postoperative patient recovery. Therefore, the quest for effective 
and risk free modulation of these deeply rooted metabolic changes has been and still is an 
unresolved priority.  
 
5.3. Postoperative insulin resistance  
The extent of acute insulin resistance after elective surgery is associated with the type and 
magnitude of operation and tissue injury 38,39. This state of metabolism is temporary and 
lasts, with large individual variation, for at least 5 days after uncomplicated open 
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cholecystectomy, after which insulin sensitivity normalizes with recovery of the patient 
40. Depending on methodological differences, type of surgery and time of measurement, 
studies on sites and detailed changes in glucose metabolism during postoperative insulin 
resistance have been somewhat divergent. During the first postoperative day insulin 
resistance has been shown to be of mere peripheral origin 12,13 or to include both hepatic 
and peripheral tissues, with metabolic alterations being most pronounced in skeletal 
muscle 4,5,12, whereas a shift towards hepatic insulin resistance occurs during the 
following days 41. A general finding is that non-oxidative glucose disposal becomes 
severely inhibited and virtually unresponsive to exogenous insulin infusion after surgery 
4,5,12,13,41, whereas rates of glucose oxidation are either unaltered 13,41 or more often 
reduced with a concurrent increase in rates of fat oxidation 4,5,12 and elevated plasma free 
fatty acids (FFA), indicating increased lipolysis with reduced fat tissue responsiveness to 
insulin 4.  
Until recently, elevated blood glucose after surgical trauma was accepted as a  
necessary part of convalescence. This perception changed however, as hyperglycaemia, 
the most prominent metabolic feature of insulin resistance, was shown to be severely 
detrimental to postoperative intensive care patients in a landmark clinical, prospective, 
randomized study comparing intensive insulin therapy and standard insulin treatment in 
mainly cardiac surgery patients 42,43. Further, a recent prospective study of 273 patients 
undergoing elective cardiac surgery has shown that for each 1 mg/kg/min decrease in 
glucose infusion rate during intraoperative hyperinsulinaemic-euglycaemic clamping as a 
measure of increasing insulin resistance, there was increased incidence of major 
complications and severe and minor infection independent of the patients preoperative 
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diabetic status 2. Hyperglycaemia has also been shown to be associated with increased 
length of stay, in-hospital complications and mortality after non-cardiac surgery in 
patients without pre-existing diabetes 44. Insulin resistance itself is suggested to be a 
better predictor of outcome than glycaemic control per se 45 and despite an increasing 
interest and research on acute insulin resistance, the underlying mechanisms are still not 
fully understood.  
 
5.4. Insulin signalling 
Insulin regulation of glucose uptake is mediated via complex intracellular signalling 
pathways 46 (Fig. 1). The insulin receptor consists of two intracellular β-units which are 
activated by trans-autophosphorylation following binding of insulin to two extracellular 
α-subunits.  This enables the receptor to phosphorylate several downstream targets. 
Among these targets, the insulin receptor substrates (IRS) are crucial for the organisation 
and initiation of insulin`s metabolic actions 47. Once activated, IRS1 recruits to the cell 
membrane phosphoinositide-3-kinase (PI3K), which then catalyses the phosphorylation 
of phosphatidylinositol 4,5-bisphosphate ( PIP2) to phosphatidylinositol 3,4,5-
trisphosphate (PIP3). The downstream proteins phosphoinositide-dependent protein 
kinase (PDK1) and Akt1 are also recruited to the inner surface of the plasma membrane 
followed by phosphorylation of Akt1 on Thr308 by PDK1. The additional phosphorylation 
on Ser473 by mTOR complex 2, which also is activated by PI3K, is prerequisite for full 
activation of Akt1 48. Together with signalling through an alternative pathway, the 
activation of Akt1 results in translocation of glucose transporter protein GLUT4 from 
intracellular deposit vesicles to the plasma membrane. Akt1 also inactivates glycogen 
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synthase kinase 3 β and thereby abrogates its restraining effect on glycogen synthase, 
facilitating the formation of glycogen from glucose. By inhibitory serine residue 
phosphorylation on forkhead transcription factor 1 (FOXO1) by Akt1, insulin reduces 
mRNA expression of pyruvate dehydrogenase kinase 4 (PDK4), a key inhibitor of the 
pyruvate dehydrogenase complex, which regulates the flux of glucose derived pyruvate 
into the mitochondria.  
 
Figure 1 Insulin signalling 
 
5.5. Counter-regulatory hormones and acute insulin resistance  
The initiation and course of the metabolic stress response is orchestrated by a complex 
interrelated triad of nervous, endocrine and humoral systems. Perception of injury, tissue 
damage and fluid loss by afferent neurogenic stimuli from the site of tissue damage, and 
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from baro- and volume-receptors is followed by increased secretion of pituitary 
hormones and activation of the sympatho-adrenergic axis 49,50. Thus, the ‘ebb’ phase is 
dominated by a time limited neuroendocrine response with a classic signature of elevated 
levels of catecholamines, cortisol and glucagon. Because these so-called stress hormones 
respond to, and are capable of counteracting hypoglycaemia, they are also called counter-
regulatory hormones 51. The counter-regulatory hormones work in concert, with 
complementary and additive effects on creating and maintaining hyperglycaemia and 
insulin resistance during stress.  
The ‘ebb’ phase is later succeeded by the hypermetabolic ‘flow’ phase, 
characterized by catabolism and followed by a gradual shift into an anabolic state of 
recovery. During the ‘flow’ phase the counter-regulatory hormones usually normalize 
and insulin levels elevate to above normal 26,52. The features of stress metabolism after 
injury can, in part, be mimicked by prolonged infusion of a hormone cocktail containing 
cortisol, glucagon and catecholamines 53,54. However, the plasma concentrations needed 
in order to induce such metabolic alterations in otherwise healthy volunteers are 
substantially higher than those seen in patients with a similar metabolic profile 24. Also, 
in patients undergoing elective surgery, investigations have shown discrepancy in the 
extent, duration, correlation and timing of the elevation of counter-regulatory hormones 
and the course of stress metabolism 7,38,40,52,55. The transient and moderate rise in stress 
hormones during and immediately after surgery is not synchronous with the much longer 
lasting postoperative insulin resistance and catabolic state. Thus, the traditional view of 





Glucagon stimulated glycogenolysis is one of the most sensitive metabolic effects of 
hormones on any tissue 56. The effect of glucagon alone on glucose output from the liver 
is transient, lasting only a couple of hours 57,58 and does not make a major contribution to 
the hyperglycaemic response after surgery 1. The extent and duration of hyperglycaemia 
is limited due to counteracting elevation of insulin levels and an indirect increase in 
glucose clearance 57. However, when glucagon is infused in dogs in combination with 
cortisol, the increase in glucose production becomes sustained indicating synergistic and 
potentiating effects 57. Glucagon also has a central role in sustaining hyperglycaemia 
during stress hormone infusion, by reducing hepatic glucose uptake, increasing hepatic 
uptake of peripherally released lactate and alanine and stimulating gluconeogenesis 59,60. 
Acute actions of glucagon on free fatty acid metabolism remain controversial. Up-
regulation of hormone-sensitive lipase activity and increased release of glycerol has been 
reported by in vitro studies on rat adipocytes 61 and in vivo in humans 62. However, no 
such effect of glucagon concentrations within the physiological range was seen in more 
recent studies in humans 63 or in swine 64. 
 
5.5.2. Epinephrine and norepinephrine 
Like glucagon, epinephrine has a transient, but smaller increasing effect on glucose 
production. When infused together with glucagon it aggravates hyperglycaemia by 
further increasing gluconeogenesis in addition to the glycogenolytic effects of glucagon 
57,65. The persistent hyperglycaemia seen during infusion of epinephrine is due to its 
direct negative effects on peripheral glucose uptake and, at relatively high circulating 
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levels 66, inhibition of insulin secretion 57,66. In general, circulating levels of insulin are 
acutely suppressed by epinephrine after major injury, although this specific effect of 
epinephrine has a threshold 66 and insulin secretion in the immediate period following 
less severe trauma can vary extensively 67-70. Epinephrine is a cardinal inductor of 
lipolysis and release of FFA and glycerol from adipose tissue into circulation by 
stimulating hormone-sensitive lipase. Whereas a 4-5 fold increase in circulating levels of 
epinephrine is required to induce hyperglycaemic responses, the lipolytic effects of 
epinephrine occur at lower levels 71. Due to the mechanisms of the glucose-fatty acid 
cycle (chapter 5.6.2.), increased availability of FFA also leads to decreased glucose 
uptake by competitive inhibition of glucose oxidation. Norepinephrine is mainly a 
sympathetic neurotransmitter and its metabolic actions as a hormone, resulting from 
synaptic “spill over”, are similar to those of epinephrine, but are of less magnitude in 
dogs 72 and require much higher circulating concentrations in humans 73. In swine, 
research indicate higher β-adrenergic lipolytic potency of norepinephrine than of 
epinephrine 64.  
 
5.5.3. Cortisol  
Circulating concentrations of cortisol is a strong predictor of stress induced insulin 
resistance after surgery 6. An increase in blood sugar and both hepatic and peripheral 
insulin resistance, as indicated by increased endogenous glucose release (EGR) and 
decreased whole-body glucose disposal (WGD) during hyperinsulinemic clamp studies, 
has been demonstrated six hours after acute cortisol excess in man 74. Importantly, these 
metabolic effects persisted after normalization of plasma cortisol levels 74. Other 
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investigators have reported development of insulin resistance exclusively in peripheral 
tissues and preserved suppressive effects of insulin on EGR after 2 days of glucocorticoid 
treatment, using the glucose clamp technique 75. Cortisol induced insulin resistance can 
be ascribed to different post-receptor defects in the insulin signalling pathway 76,77, which 
are more pronounced in muscle, at least after several days of cortisol excess 77. More 
specifically, inhibition of insulin induced phosphorylation of the insulin receptor 78, 
decreased muscle IRS1 expression 78, inhibited phosphorylation of Akt1 79 and a decrease 
in translocation of GLUT4 transporters to the cell membrane 80,81 has been demonstrated 
after cortisol excess for 2-12 days. Insulin stimulated glycogen production is reduced 80,82 
and a shift from glycogen synthesis to glycolysis provides normal production of lactate 80, 
which constitutes an important substrate for gluconeogenesis. Cortisol further maintains 
gluconeogenic precursor supply by increasing protein breakdown, and liberation of 
amino acids, especially alanine 74,83. Independently of glucose transport, a decrease in 
oxidative glucose disposal is seen both in rats 80 and in healthy volunteers 75 through 
increased pyruvate dehydrogenase kinase 4 (PDK4) expression 84 and/or increased 
plasma FFA levels and oxidation 85.  
 
5.6. Regulation of glucose oxidation  
5.6.1. The glucose-fatty acid cycle  
Glucose and fatty acids comprise approximately 80% of oxidative metabolism in humans, 
whereby the total reciprocal utilization of these substrates to a great extent is controlled 
by insulin secretion 86. In order to tightly adjust adenosine triphosphate (ATP) production 
to the actual needs of the body, several regulatory mechanisms on different levels, 
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originally described by Randle 87, co-ordinate and fine-tune the utilization of glucose and 
fatty acid in skeletal muscle mitochondria. Elevated levels of circulating glucose 
stimulate insulin secretion, which in turn suppresses the action of hormone sensitive 
lipase and the release of free fatty acids from adipose tissue. Further, the resulting 
increase in glucose oxidation reduces fatty acid oxidation through malonyl-CoA 
inhibition of carnitinepalmitoyl-transferase-1, which is responsible for transport of fatty 
acids into the mitochondria. These mechanisms arrange for unimpeded insulin-stimulated 
glucose disposal with less competition from FFA in times when glucose is abundant. In 
the fasting state, at low serum glucose and insulin concentrations, FFA levels rise in order 
to provide fuel for oxidative ATP production in skeletal muscle. The increase in β-
oxidation of fatty acids suppresses muscle uptake and oxidative disposal of glucose by 
inactivating the pyruvate dehydrogenase complex (PDC) which regulates the flux of 
carbohydrate derived pyruvate into the mitochondria. Suppression of PDC activity is 
crucial in order to conserve glucose, because no metabolic pathway for conversion of 
Acetyl-CoA to glucose exists in mammals 88.  
 
5.6.2. Pyruvate dehydrogenase kinase 4  
The activity of PDC is controlled by a covalent mechanism involving a competing 
pyruvate dehydrogenase kinase (PDK) and phosphatase (PDP) reaction cycle 89. The 
resulting inter-conversion cycle determines the amount of PDC existing in non-
phosphorylated (active) form 90. The PDK protein family comprises of four isoforms 
(PDK1-4) 91, whilst PDP has two isoforms (PDP1-2) 92. Although the PDK isoform 
proteins are expressed in most tissues, including liver, skeletal and heart muscles, the 
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specific activity of PDK4 is several-fold greater than any other member of this protein 
family 91, thereby assigning to PDK4 isoform the greatest regulatory significance. PDK4 
reduces the rate of glucose oxidation by inhibition of PDC activity. Increased muscle 
PDK4 expression has been observed in rodent streptozotocin- 93,94 and high-fat diet-
induced insulin resistance models 95, but the causal relationship between insulin 
resistance and PDK4 expression and the mechanisms underlying the regulation of this 
gene is still a subject of investigation. FFA activated signalling via peroxisome 
proliferator-activated receptor (PPAR) α induces PDK4 gene expression 96, but this is not 
obligatory in skeletal muscle 97,98, where another transcription factor, forkhead 
transcription factor 1 (FOXO1), has been shown to play a key role 84,99. Further, PDK4 
expression is elevated by cortisol and reduced by insulin 96. The acute and pronounced 
suppressive effect of insulin on skeletal muscle PDK4 expression is independent of its 
restraining effect on plasma FFA 98 and interestingly, the effect is impaired in acute 
insulin resistance induced by lipid and lactate infusion 100.  
 
5.7. Regulation of PDK4 expression by cortisol and insulin  
During conditions characterized by higher-than-normal circulating levels of FFAs, acute 
glucocorticoid excess or reduced insulin availability, it appears that up-regulation of 
PDK4 mRNA and protein is due to up-regulation of FOXO1 activity 84. Cortisol-induced 
elevation of muscle PDK4 mRNA and protein expression is modulated by complex 
hormone response units including enhanced binding kinetic of FOXO1 protein to its 
promoter on the PDK4 gene, which increases its responsiveness to the glucocorticoid 
receptor. On the other hand, FOXO1 is known to be regulated by the IRS1/Akt1 
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signalling pathway 101 and plays a key role in the inhibition of PDK4, as insulin 
stimulation, in addition to dissociating the glucocorticoid receptor from the PDK4 gene, 
leads to phosphorylation of FOXO1, which inhibits translocation into the nucleus and 
binding to the promoter 102 (Fig. 1).  
Thus, the cellular PDK4-regulating pathways of insulin and cortisol interact at the 
level of FOXO1, which plays an important role in both the induction and inhibition of 
PDK4 gene expression.  
 
5.8. The inflammatory response to surgery and its effects on insulin signalling  
Research on links between the immune system, proinflammatory cytokines and metabolic 
disorders has increased tremendously during the last decades 103 and there is a growing 
understanding that obesity, type 2 diabetes and the metabolic syndrome are caused by 
chronic low-grade systemic inflammation 104. The proinflammatory cytokines tumor 
necrosis factor α (TNFα), interleukin (IL) -1β and IL-6 in particular, have also been 
objects of investigation on the search for humoral mediators of insulin resistance 
subsequent to surgical trauma. TNFα is released into the peritoneal cavity after major 
abdominal surgery 105. Further, it has been shown that major elective abdominal surgery 
induces a systemic pro-inflammatory response, as seen by elevations in plasma IL-1β and 
IL-6 levels 20,106,107 lasting up to 3 days postoperatively. Especially the IL-6 response 
correlates well with the extent and duration of surgery 108 and development of 
postoperative insulin resistance 6,7 and together with cortisol, IL-6 is one of the strongest 
predictors of acute insulin resistance after surgery 6. The source of these inflammatory 
mediators, primarily acting in auto- and paracrine manners, is mainly local monocytes 
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and macrophages activated by tissue damage. Extensive inflammatory activity leads to 
spill-over of cytokines into circulation, enabling the cytokines to exert humoral effects on 
cells and tissues distant from the site of injury.  
Pro-inflammatory cytokines activate the serine/threonine kinases inhibitor κB  
kinase (IKKβ) and c-Jun N-terminal kinase (JNK), which impair the downstream 
propagation of insulin signalling by inhibitory phosphorylation of Ser307 on IRS1. These 
alterations in insulin signalling are seen in insulin sensitive tissues in chronic insulin 
resistant states 109 as well as in skeletal muscle during acute insulin resistance after 
surgery 8. Further, previous studies have shown rapid up-regulation of JNK expression 
after surgery 110, increased ratio of phosphorylated to total JNK in muscle after burn 
injury 111 and an association between activation of JNK and IKKβ and increased 
inhibitory Ser307/312 IRS1 phosphorylation in the liver immediately after trauma and 
haemorrhage in rodents 112, and in skeletal muscle following TNFα infusion in healthy 
humans 113.  Equally, suppressor of cytokine signalling 3 (SOCS3), which binds to IRS1 
and targets it for proteasome degradation 114, is rapidly up-regulated in the liver following 
lipopolysaccharide-induced endotoxemia in rodents 115 and in skeletal muscle after major 
abdominal surgery 9.  
The latter patient-based study did cover a broad range of genes (45 genes), which  
collectively provided enough evidence to support the contention that several important 
genes involved in inflammatory pathways, such as IL-6 and TNFα 9, are activated in the 
muscle (rectus abdominis) next to the site of surgery. In line with these observations, 
nuclear factor кB (NFкB), which is a transcription factor that enhances the nuclear 
inflammatory response following activation by a variety of extra cellular inflammatory 
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signals, is persistently up-regulated both in chronic inflammatory diseases 116 and in 
skeletal muscle after surgery 9. 
 
5.9. Oxidative stress-induced insulin resistance and mitochondrial uncoupling  
Mitochondrial production of ATP through oxidative phosphorylation constitutes the  
core of aerobic metabolism. An unavoidable consequence of this process is the formation 
of reactive oxygen species (ROS) by interaction of free electrons and oxygen 117. In both 
skeletal muscle and liver, mitochondria in addition to NADPH oxidase, are thought to be 
the most important source of superoxide (O2•-) and subsequently hydrogen peroxide 
(H2O2) 118 release. These are highly reactive molecules capable of destroying cellular 
functional and architectural components and membranes due to direct contact or lipid 
peroxidation. Due to their destructive nature ROS are scavenged by an array of intrinsic 
defence systems in the cell, including several different forms of superoxide dismutase, 
catalase and glutathione peroxidase which convert O2•- into oxygen and H2O2, which is 
further quickly broken down into water and oxygen by catalases 117. In addition, 
mitochondrial proton leakage can be increased by uncoupling proteins (UCP) as a 
feedback-mechanism to decrease ROS production, which leads to less effective 
mitochondria with decreased potential for energy production 119.  
In chronic insulin resistant states, mitochondria display decreased oxidative 
capacity and increased ROS release and lipid-induced uncoupling, probably due to 
increased substrate availability resulting in lipotoxicity and alterations in the 
mitochondrial membrane structure and electron transport 118,120,121. Aside of being a by-
product of oxidative metabolism, recent evidence  supports the role of ROS as a regulator 
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molecule and as an inductor of insulin resistance through activation of the 
aforementioned stress-induced serine/threonine kinases, such as IKKβ and JNK 118,122,123 
or by direct oxidative modification of the insulin receptor and/or phospho tyrosine 
phosphatases 124,125, leading to impairment of insulin signalling. In addition, in vitro 
research models have identified a direct correlation between insulin resistance and 
mitochondrial O2•- without consistent change in the upstream insulin signal transduction 
pathway 126,127, indicating IRS1/Akt1-independent regulatory properties of ROS on 
insulin sensitivity through not yet identified mechanisms. 
Lipolytic activity stimulated by the hormonal changes after surgery leads to  
conversion of stored triglycerids into glycerol and fatty acids, although their plasma 
concentrations may not change markedly 1. In skeletal muscle an acutely (1 h) increased 
supply of palmitic acid within physiological plasma concentrations has shown to induce a 
rise in mitochondrial ROS production 128. In addition, hyperglycaemia per se induces 
mitochondrial ROS overproduction 129 and most intriguingly, in vitro and in vivo rodent 
studies have shown that ROS has a causal role in multiple forms of insulin resistance in 
skeletal muscle, adipose tissue and liver, including glucocorticoid-, TNFα- and trauma 
and haemorrhage-induced acute insulin resistance, which could all be reversed or 
prevented by antioxidant treatment and/or pharmacologic and genetic strategies that 
override mitochondrial O2•- production 11,127,130. Further, glucocorticoids 131 and TNFα 132 
inhibit oxidative phosphorylation, causing ineffective and dysfunctional mitochondria, 
and increased levels of skeletal muscle UCP2 and UCP3 mRNA and protein expression 
has been shown to develop along with insulin resistance after surgical trauma in rats 133. 
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These findings collectively indicate that increased ROS levels constitute an important 
pathophysiological factor in the development of both acute and chronic insulin resistance.  
 
5.10. From preoperative ‘nil-per-mouth’ to preoperative oral carbohydrate 
loading  
The tradition of preoperative fasting originates from the era when general anaesthesia 
was introduced in the mid-19th century. In 1848, less than a year after the discovery of its 
anaesthetic effects, a 15 year old girl suffered the first registered anaesthesia death after 
chloroform inhalation for removal of a toe-nail 134. Although the cause of her death was 
not clear, and later became extensively debated, the autopsy revealed a stomach distended 
with food and signs of pulmonary aspiration 135. Subsequently, preoperative fasting in 
order to avoid anaesthesia-related vomiting and pulmonary acid aspiration was proposed 
only a few years after the very first implementation of general anaesthesia 136. The dogma 
of preoperative ´nil-per-mouth´ after midnight was upheld until the early 1980s, when it 
was challenged by several clinical trials. Based on the data from these trials, new national 
guidelines were approved and implemented in Norway in 1994, followed by several other 
countries, including the US, the UK, Denmark and Sweden, allowing a light breakfast 
and preoperative oral liquids until 6 and 2 h before general anaesthesia, respectively 18,137. 
About the same time, the first investigations into preoperative carbohydrate 
supplementation to reduce postoperative insulin resistance was performed and the authors 
showed that insulin sensitivity decreased significantly less after elective open 
cholecystectomy in patients who received an overnight infusion of 5 mg/kg/min glucose 
compared to traditional fasting. It was speculated that enzymatic changes favouring 
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gluconeogenesis and active preoperative carbohydrate preservation could play a role for 
this finding, because no differences in hormone concentrations between the groups were 
seen 55,138. Complete maintenance of insulin sensitivity postoperatively was later 
achieved in patients undergoing total hip replacement when a prolonged 
hyperinsulinaemic-euglycaemic clamp initiated 3 h preoperatively and continued 
throughout surgery was used to induce continuous perioperative hyperinsulinaemia 139. 
The patients in the control group exhibited a catabolic hormone profile, in contrast to the 
insulin treated patients who had significantly lower circulating concentrations of cortisol, 
glucagon and insulin-like growth factor binding protein, in addition to lower free fatty 
acids and fat oxidation rates. It was concluded that the principal mechanisms of action of 
the clamp treatment were minimization of the endocrine stress response and the change 
of the preoperative metabolic setting from a fasted to an absorptive state 139.  
A CHO rich beverage was then developed and tested safe for ingestion up to 2  
h prior to commencement of surgery 140 and administration of a large dose of 800 ml (100 
g CHO) in the evening before surgery and a smaller dose of 400 ml (50 g CHO) 
immediately prior to surgery has since become established routine 16. This regimen of 
preoperative oral CHO loading has been shown to reduce development of peripheral 
insulin resistance on the first postoperative day after colorectal surgery compared to 
overnight fasted patients, without any effect on hepatic insulin sensitivity or counter-
regulatory hormones 12. Based on indirect calorimetry data, the authors concluded that the 
improved insulin sensitivity was due to better maintenance of glucose oxidation 12. The 
same results were found when the effect of the beverage on development of insulin 
resistance immediately after total hip replacement surgery was examined 13. Additional 
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analyses revealed a plausible relation between increased rates of glucose oxidation and 
decreased pre- and intraoperative plasma levels of FFA and fat oxidation rates. 
Interestingly, the effect persisted into the postoperative period, and was further enhanced 
during exogenous insulin infusion, when plasma levels of FFA were again equal to those 
in fasted patients 13. However, as the authors pointed out, it could not be proven whether 
the effect of the carbohydrate drink was specific in blunting surgery-induced insulin 
resistance or if the mechanism underlying the improvement in insulin sensitivity was of 
general character independent of the surgical trauma.  
It has later been shown that whole-body insulin sensitivity is increased in non- 
operated healthy volunteers three hours after ingestion of the morning dose, but is 
unaffected by the CHO load given in the previous evening 19. This indicates a 
predominant role of the CHO load administered in the immediate preoperative phase and 
that the effect of the CHO drink on insulin sensitivity could be of general character such 
as facilitated glucose disposal, also known as the Staub-Traugott effect (see next section). 
In addition, this finding and the fact that modern fasting guidelines allow patients to eat 
until 6 h prior to surgery 141 puts a question mark to the relevance of the evening CHO 
dose and the extent to which it contributes to reduce postoperative insulin resistance. 
Recently, a significant reduction in circulating concentrations of IL-6, one of the  
strongest predictors of postoperative insulin resistance 6, was demonstrated together with 
attenuated development of insulin resistance in CHO loaded patients until the 3rd day 
after major abdominal surgery 20. Further, in patients scheduled for laparoscopic 
cholecystectomy, preoperative administration of a carbohydrate-based oral nutritional 
supplement containing glutamine and antioxidants has been shown to reduce 
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intraoperative plasma FFA concentrations and skeletal muscle metallothionein 1A 
mRNA expression, an indicator of oxidative stress 142. The same study also showed a 
reduction in muscle PDK4 gene- and protein expressions compared to preoperatively 
fasted patients indicating reversal of starvation-induced changes in PDK4 143, although it 
was not possible to attribute these effects to a specific constituent of the drink. 
Thus, the mechanisms by which preoperative CHO intake inhibits development of  
postoperative insulin resistance and to which extent each of the CHO loads administered 
as part of the established clinical routine contributes to postoperatively enhanced insulin 
sensitivity is still poorly understood.  
 
5.11. Facilitated glucose disposal / Staub-Traugott effect 
 
Ingestion of 15 – 50 g of glucose is followed by an increase in peripheral insulin action 
and enhanced glucose disposal within ~3 h in non-operated healthy volunteers 19,144. 
Based on these findings, it has been suggested that triggering of facilitated glucose 
disposal (also known as the Staub-Traugott effect) and maintenance of this effect into the 
postoperative phase could explain the improvement in insulin sensitivity seen after 
surgery in preoperatively CHO loaded patients 145. The Staub-Traugott effect was 
discovered almost a century ago 146-148, is characterized by improved glucose tolerance to 
sequential glucose loading and constitutes a physiologic factor in day-to-day glucose 
homeostasis. Research on the physiological mechanisms underlying the Staub-Traugott 
effect has been largely equivocal and the potential contribution to the prophylactic effect 
of preoperative CHO loading is therefore difficult to determine. The causes of the Staub-
Traugott effect are suspected to be multifactorial and may even gradually come into play 
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with increasing demands on glucose homeostasis 149, including enhanced glucose 
potentiation of insulin secretion by incretins and increased suppression of hepatic glucose 
release 150, decreased hepatic insulin clearance 149, suppression of free fatty acids 151 or 






















6. AIMS OF THE STUDIES 
Despite the last decade’s increasing interest and research, the mechanisms underlying the 
development of postoperative insulin resistance and the prophylactic effect of 
preoperative carbohydrate treatment remain enigmatic. However, pathophysiological 
similarities between chronic and acute insulin resistant states exist. On this basis, the 
present thesis has the following aims: 
 
Paper I:  
To establish hyperinsulinaemic-euglycaemic step clamping with tracer glucose infusion 
and labelled glucose infusate for assessment of acute insulin resistance in pigs and to 
evaluate whether the premises for utilization of the technique would be altered by 
surgical instrumentation needed in order to combine this technique with invasive 
investigative methods.  
 
Paper II:  
To test the hypothesis that a single dose of preoperative oral CHO treatment 2 h prior to 
surgery is sufficient to maintain insulin sensitivity in the immediate postoperative phase. 
We further wanted to investigate the basis of such an effect and whether it is limited to 
pigs exposed to surgical trauma or if it is of general character, such as the Staub-Traugott 
effect.  
 
Paper III:  
To test the hypothesis that preoperative oral CHO supplementation reduces the 
magnitude of surgery-mediated inflammatory responses and impairment of insulin signal 
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transduction in skeletal muscle, thereby ameliorating insulin inhibition of muscle PDK4 
expression in the immediate postoperative phase.  
 
Paper IV:  
To assess the change in mitochondrial functions with special focus on pyruvate oxidation 
capacity, levels of ROS release and uncoupling in skeletal muscle and liver mitochondria 



















7. MATERIALS AND METHODS 
 
7.1. Ethical approval 
 
The study protocols were approved by the committee of the Norwegian Experimental 
Animal Board and all experiments were conducted in compliance with the institutional 
animal care guidelines and the National Institute of Health’s (NIH) Guide for the Care 
and Use of Laboratory Animals [Department of Health and Human Services Publication 
no. (NIH) 85-23, revised 1985]. 
 
7.2. Animals, anaesthesia and instrumentation  
Locally bread Yorkshire/Landrace hybrid pigs (~30 kg) were stalled and acclimatized in 
the animal research facilities for a week before experiments. Animals were submitted to a 
12:12-hr light-dark cycle, a standardized diet and ad libitum access to water. The 
experiments were commenced between 6 and 7 a.m. Following sedation by intramuscular 
injection of 15 mg/kg ketamine, 1 mg/kg midazolam and 1 mg atropine and mask 
inhalation of 4% isoflurane in 100% O2 the pigs were orotracheally intubated and gas 
anaesthesia was continued throughout the experiments at a minimal alveolar 
concentration of 0.8-1.5% mixed with 40-60% oxygen (Paper I-III) or with nitrous oxide 
and oxygen (40/60%) (Paper IV). Deep anaesthesia was induced through an i.v. bolus of 
0.01 mg/kg fentanyl and maintained with i.v. infusion of 0.02 mg/kg/h fentanyl and 0.3 
mg/kg/h midazolam. Respiration and minimal alveolar isoflurane concentration were 
monitored and anaesthesia was adjusted according to blood gas analysis and snout reflex 
tests. The general experimental setup and instrumentation is described in detail in paper 1 
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and is shown in figure 2. Paper specific surgical procedures are described in 7.6. and 














Figure 3 Paper specific procedures 
             
 A    Paper I: Substudy A                                                             B    Paper I: Substudy B 










E  Paper IV:  
     Experimental day 1               Experimental day 2                                 Experimental day 3        
 
 
7.3. Assessment of acute insulin resistance 
 
. The “gold standard” for assessment of insulin sensitivity, hyperinsulinaemic-
euglycaemic clamping (HEC) was first introduced in 1979 by DeFronzo et al 152 and is 
based on infusion of insulin at a constant rate, while simultaneous infusion of glucose is 
titrated to euglycaemia. Aside from non-insulin dependent glucose uptake and residual 
endogenous release of glucose, the steady-state (SS) glucose infusion rate (GIR) equals 
the amount of glucose utilized in peripheral insulin sensitive tissues and thus, HEC gives 
a picture of whole body insulin sensitivity. The major advantage over other methods of 
insulin sensitivity measurement is that the investigator is in control of both insulin and 
glucose levels. In order to separate changes in hepatic from peripheral insulin sensitivity, 
i.e. changes in rates of EGR from rates of WGD, HEC can be combined with tracer 
dilution methodology 153. Prior to HEC, basal EGR and WGD are calculated during 
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infusion of glucose tracer. The tracer infusion is then continued during the subsequent 
HEC and glucose kinetics are calculated based on non-SS equations and the SS GIR 
necessary to maintain euglycaemia. Further development of this method has shown that 
maintenance of constant tracer enrichment during clamping minimizes dependency on 
non-SS equations and generates more accurate data. A frequently used procedure is 
labelling of the glucose infusate at an atom percent enrichment approximately equal to 
that measured during basal SS condition, so-called hot-GINF HEC. If a stable glucose 
tracer is used, knowledge of the approximate level of basal SS tracer enrichment is 
prerequisite for correct labelling because immediate analysis during the procedure is not 
feasible.  
The liver and peripheral tissues generally exhibit different degrees of insulin  
sensitivity 154 and insulin resistance can be caused by unresponsiveness or insensitivity to 
the hormone, or a combination of both 155. Therefore, hot-GINF HEC performed at 
stepwise increasing insulin infusion rates, so-called step clamping, gives more detailed 
information about sites, degrees and specific features of insulin resistance than a clamp 
performed at a single insulin infusion rate.  
 
7.4. Measurement of tracer enrichment  
Serum concentrations of the stable glucose tracer D-6,6-2H2-glucose used in combination 
with HEC for the measurements of insulin sensitivity in the present experiments were 
analyzed by LC/MS/MS using Waters Acquity™ UPLC system (Waters, Milford, MA, 
USA) with an autosampler and a binary solvent delivery system interfaced to Waters 
Micromass® Quattro Premier™ XE benchtop tandem quadrupole mass spectrometer 
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(Waters, Manchester, UK) (technique described in detail in paper 1). For quantitative 
analysis, the following MRM transitions were used: m/z 179→89 and m/z 179→119 for 
glucose, m/z 181→89, m/z 181→91 and m/z 181→121 for D-[6,6-2H2]glucose and MRM 
transition m/z 185→92 and m/z 185→123 for the internal standard D-[13C6]glucose. 
Isotopic enrichment was calculated as tracer-to-tracee ratio after subtracting the isotopic 
enrichment of a background serum sample. An aliquot of the D-[6,6-2H2]glucose 
infusate was analysed for the isotope concentration to calculate the actual infusion rate 
for each infusion experiment. 
 
7.5. Calculation of glucose kinetics 
 
Total glucose appearance rate (Ra) and WGD were calculated using modified versions of 




E t( ) −
pV × C t( )/ 1+ E t( )( )[ ]× dE t( )/dt( )
E t( )        and     dt
dCpVRaWGD ×−=  
 
where F is the tracer infusion rate, E is the tracer enrichment, p is the pool fraction taken 
as 0.65 156, V is the distribution volume of glucose taken as 230 ml/kg 158 and C is the 
glucose concentration. F consisted of the continuous tracer infusion alone prior to 
clamping, as opposed to during clamping where F was the sum of the continuous tracer 
infusion and tracer infused with the labelled glucose infusate during the last 40 min of 
each clamp. A linear curve was fit to the glucose concentration and tracer enrichment raw 
data by linear regression in order to minimize analytical variation and improve accuracy 




7.6. Study design 
7.6.1. Paper I  
Substudy A: The glucose tracer was given as a 150-min long primed (6 mg/kg),  
continuous (0.12 mg/kg/min) infusion. The priming dose and continuous infusions rate 
were calculated from the decline in serum enrichment after a glucose tracer bolus in 
unpublished pilot experiments. Glucose kinetics were calculated based on tracer 
enrichment measured during the last 30 min of infusion. Circulating concentrations of 
hormones were measured 10 min before and 30 min prior to the end of tracer infusion. 
The procedure was repeated following surgical instrumentation after 4 days, consisting of 
a median laparotomy and groin incision followed by dissection of the portal vein, 
common hepatic artery, right renal artery and vein, superior mesenteric artery and vein, 
and right femoral artery and vein (Figs. 3A and 4).  
Substudy B: Primed, continuous tracer infusion (basal period) was commenced 150 min 
prior to and continued throughout three consecutive clamp periods. Three 120-min long 
clamps were performed at stepwise increasing insulin infusion rates (0.2, 0.8, and 1.6 
mU/kg/min) while glucose (200 mg/ml) labelled with tracer at 2.1 atom percent 
enrichment, according to the measured level of basal SS enrichment from substudy A was 
titrated to euglycaemia at 4.5 mmol/l. Arterial tracer enrichment was measured every 10th 
min during the last 30 min of the basal and successive clamp periods. Serum insulin was 
measured 30 min prior to the end of the basal period and every 30th min during the last 
hour of the successive clamp periods. Circulating hormone and FFA concentrations were 
measured 30 min prior to the end of the basal and clamp periods. After a period of 4 days, 
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the procedure was repeated with three different insulin infusion rates (0.4, 1.2, and 2.0 
mU/kg/min) (Figs. 3B and 4). 
Substudy C. A three-step clamp with insulin infusion rates at 0.4, 1.2, and 2.0 mU/kg/min 
was performed after major surgical trauma consisting of a right-sided thoracotomy, 
midline laparotomy, total colectomy, and closure of the incisions (Figs. 3C and 4).  
 
Figure 4 Study design paper I 
 
7.6.2. Paper II 
Pilot: In order to ensure adequacy of the CHO treatment dose in regard to postprandial 
hyperglycaemic and hyperinsulinaemic response, four pigs with an indwelling single-
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lumen tunnelled central venous catheter received 200 ml of the carbohydrate beverage 
(12.6 g/100 ml carbohydrate, 79 % polysaccharides, 260 mOsm/kg, Nutricia preOp, 
Nutricia, Zoetermeer, The Netherlands). Repeated blood samples were collected from 10 
min before to two hours after complete oral administration.   
Main study: 32 pigs randomized to two surgery groups (surgery as described in paper I) 
and two non-operated time-matched control groups (each n = 8) received an oral morning 
dose of 200 ml containing 25 g carbohydrate (CHO/surgery and CHO/control) or were 
fasted overnight (fasting/surgery and fasting/control). The fasting/surgery group was used 
in paper I and II. Circulating concentrations of glucose, hormones and FFA were 
measured serially throughout the experiments and repeated hind limb muscle and liver 
biopsies were collected for measurement of glycogen content (paper II) and molecular 
analyses (paper III) (Figs. 3C and 5). Animals in the two non-operated time-matched 
control groups were treated identically except for the surgical trauma (Figs. 3D and 5).  
 
 









7.6.3. Paper III 
Open muscle biopsies sampled at commencement of and immediately after surgery, and 
during the end of the second hyperinsulinaemic-euglycaemic clamp in the fasting/surgery 
and CHO/surgery groups in paper II (Figs. 3C and 5) were analysed by fast qRT-PCR 
and IR-Western blotting. The author performing the analyses (DC-T) was blinded to the 
treatment allocations. 
 
7.6.4. Paper IV 
Eight pigs were examined in three consecutive experiments. On experimental day one the 
animals were anesthetized and preoperative levels of basal glucose turnover and 
peripheral and hepatic insulin sensitivity were assessed by tracer infusion followed by 
two-step hotGINF HEC. After three days (experimental day 2), biopsies from liver and 
skeletal muscle were sampled during anaesthesia for isolation of mitochondria followed 
by a midline laparotomy and resection of the spleen and 1.5 m of the distal small bowel 
with primary anastomosis 1 m proximal to the ileocoecal junction. Animals were brought 
back to the animal facilities for surveillance and postoperative care. On the 2nd  
postoperative day (experimental day 3), animals were re-anesthetized, followed by 
sampling of blood and biopsies and measurement of postoperative of insulin sensitivity 









7.7. Real-time PCR measurements  
Total RNA was isolated from frozen wet muscle (~30 mg) using Tri Reagent (Sigma 
Aldrich), according to the manufacturer’s protocol. Total RNA quantification, first-strand 
cDNA synthesis and real-time PCR protocols were carried out as previously described 
159. PDK4 Taqman primer/probe sets were obtained from Applied Biosystems (Foster 
City, CA, USA). The housekeeping gene hydroxymethylbilane synthase (HMBS) was 
used as an internal control. Relative quantification of gene expression was calculated 
using the 2-ΔΔCt method. The preoperative values were used as calibrator with a value of 1 




7.8. Protein extraction and Western blotting measurements  
Cytosolic and nuclear proteins were extracted from approximately 30 mg frozen wet 
muscle tissue using a modified method by Blough 160. Muscle samples were lysed in the 
presence of phosphatase and protease inhibitors and protein content was quantitated using 
a Bradford assay. Protein lysates were run on a 4-12% Bis–Tris acrylamide gel 
(Invitrogen, UK) for 2 hrs at constant voltage (200 V) and transferred to a 
polyvinylidenedifluoride membrane (PVDF) overnight at constant 100 mA, in ice-cold 
buffers (4°C) as described by Constantin et al 159. 
 
7.9. Measurement of mitochondrial respiratory activity and uncoupling 
Measurement of oxygen consumption in isolated (isolation procedures described in detail 
in paper IV) skeletal muscle subsarcolemmal (SSM) and intramyofibrillar (IFM) and 
liver mitochondria was performed by high resolution respirometry, using an oxygraph 
(Oxygraph 2k, Oroboros Instruments, Austria) with a closed 2 mL chamber at 30 °C. 
Respiration was performed in respiration medium (pH 7.4) containing (all in mmol/L): 
KCl 100, MOPS 50, EGTA 1, KH2PO4 5, and BSA 1 mg/mL. Mitochondria were added 
to the medium to give a final concentration of ~0.1-0.3 mg/mL. Respiration was 
measured with 5 mM malate + either 2.5 mM glutamate, 10 mM pyruvate or 2.5 µM 
palmitoyl-L-carnitine in separate runs. ADP (0.02 mmol/L) was added to achieve Vmax. 
Mitochondrial leak oxygen consumption (Voligo) was recorded after depletion of ADP and 
addition of 4 µg/mL oligomycin. To estimate mitochondrial proton leakage through ANT 
and UCP 2/3, 25 µmol/L carboxyatractyloside (ATR) and 500 µmol/L guanosine-
diphosphate (GDP) were added and VATR+GDP was recorded after addition of oligomycin. 
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To estimate the postoperative change in the effect of ATR+GDP, pre- and postoperative 
∆Vuncoupling calculated as Voligo  - VATR+GDP were compared.  
 
7.10. Measurement of mitochondrial ROS release 
H2O2 was estimated fluorometrically by oxidation of Amplex Red (non-fluorescent) to 
resofurin (fluorescent), as described by Schönfeldt et al. 161 with modifications. Briefly, 
isolated mitochondria were added (~0.3 mg/mL) to a respiration buffer containing malate 
+ glutamate or palmitoyl-L-carnitine (PC) and oligomycin (as in respiration 
measurements). For estimation of H2O2 release, 50 µmol/L Amplex Red and 2 IU/mL of 
horseradish peroxidase were added to the suspension, allowing Amplex Red oxidation by 
H2O2. Superoxide (O2·-) release was estimated fluorometrically as described by Johnson-
Caldwell et al. 162. Briefly, the same mitochondria suspension as for H2O2 release was 
prepared and 5 µmol/L MitoSOXred was added. All samples were then added to a 96 well 
microplate and O2·- and H2O2 were measured simultaneously in separate wells. Release of 
O2·- was monitored at ex 510 nm/em 580 nm and release of H2O2 was monitored at ex 
571 nm/em 585 nm at 30 °C, using a spectrofluorometer (Spectramax Gemini EM). The 
production of H2O2 was calculated as the increase in relative fluorescence (RF)/min over 








8. SUMMARY OF RESULTS 
8.1. Paper I 
In paper I, we established insulin dose-response curves for hepatic and peripheral insulin 
sensitivity (Substudy B) (Fig. 8) and verified the applicability of this technique for 
assessment of acute insulin resistance in anesthetized pigs (Substudy C) by performing a 
series of studies with 3-step HEC in combination with glucose tracer infusion and 
labelled glucose infusates (Fig. 7).  
 
Figure 7 Step-clamp timelines during step hot-GINF HEC procedures (n=8). GIR, glucose infusion rate; 
APE, glucose tracer atom percent enrichment; S-glucose, serum glucose. Data are means ± SE. 
 
We further found that instrumentation and dissection needed for combination of the 
technique with other investigative methods such as regional blood flow measurements 
and sampling did not elicit alterations in the hormonal milieu (Table 1) or glucose 
homeostasis that would change the premises for correct labelling of the glucose infusates 
(Table 1). Higher serum insulin concentrations, probably caused by decreased metabolic 
insulin clearance rate were found after surgery (Fig. 8), which should be kept in mind 




Figure 8  Calculated endogenous glucose release 
(EGR) and whole-body glucose disposal (WGD) 
from both step hot-GINF HEC procedures in 
substudy B (anaesthesia only; n=8) and the step 
hot-GINF HEC performed after major surgery 
(surgery; n=8) plotted vs. serum insulin (S-
insulin) levels. Data are means ± SE                  
 
Figure 9  Relative changes in EGR and WGD 
from basal at low (clamp 2 in substudy B vs. 
clamp 1 in substudy C) and high (clamp 6 in 
substudy B vs. clamp 2 in substudy C) serum 
insulin (n=8). Data are means ± SE. *P<0.01; 
**P=0.001; ***P<0.001 vs. anaesthesia only. 
 
Table 1 Substudy A: circulating hormone concentrations  
 




8.2. Paper II 
In paper II , the pilot study revealed that a dose of ~0.85 g CHO pr kg bodyweight, which 
is equivalent to the standard morning dose given to humans, induces hyperglycaemia and 
a concomitant uniform rise in serum insulin similar to the levels seen in human studies 
140,163 (Fig. 10). 
 
Figure 10 Serum glucose and 
insulin in four separate pigs 
plotted against time after 
administration of an oral 
carbohydrate (CHO) load of 






In the main study, the same single CHO dose was then shown to increase the GIR needed 
to maintain euglycaemia during the last 40 min of each step-clamp in the CHO/surgery 
compared with the fasting/surgery group (Fig. 11A), indicating increased postoperative 
whole-body insulin sensitivity after preoperative CHO supplementation. The non-
operated control groups exhibited equal whole-body insulin sensitivity (Fig. 11B), 




Figure 11 Glucose infusion rate (GIR) and 
serum insulin during three consecutive 
hyperinsulinaemic-euglycaemic clamps at 
stepwise increasing insulin infusion rates (0.4, 
1.2 and 2.0 mU/kg/min) plotted against time in 
fasted and CHO treated operated (A) and non-
operated control animals (B). Each group n=8. 
Data are means ± SE. *Significantly different 
from fasting surgery, one symbol P<0.05; two 
symbols P<0.02 (Student’s independent t-test). 
#Significantly different from corresponding 
control group, P<0.001 (Student’s independent  
t-test). The fasting/surgery group is the same 
group shown in figure 7. 
Due to different insulin serum concentrations during clamping (Fig. 11), insulin 
sensitivity in the fasting and CHO treated groups was compared at ~40 µU/ml (i.e. clamp 
2 in the surgery groups vs. clamp 3 in control groups). A 29% lower SS GIR was seen 
after surgery in fasted pigs whereas the decline in CHO treated pigs did not reach 
statistical significance (-15%, P=0.088) (Fig. 12A). Compared to their non-operated 
controls, surgery induced a 41% decline in insulin-stimulated WGD at ~40 µU/ml serum 
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insulin in fasted pigs. The postoperative decline was reduced to a mere 16% in CHO 
treated pigs (P=0.180) (Fig. 12B). No effect of CHO treatment was seen on hepatic 
insulin sensitivity (Fig. 12C) or glycogen content in liver and muscle after surgery. 
 
Figure 12 Postoperative glucose infusion rate 
(GIR) (A) and insulin stimulated whole-body 
glucose disposal (WGD) (B) during clamping at  
~40 µU/ml s-insulin in fasted and carbohydrate 
treated animals (CHO) compared to their 
respective control groups. Each group n=8. Data 
are means ± SE. ***Significant difference by 





Preoperatively fasted and CHO supplemented pigs displayed an equal increase in serum 
cortisol concentrations during the experiments compared to their respective non-operated 
controls. Glucagon was increased in CHO/surgery compared to CHO/control during the 
low insulin clamp (Fig. 13).  
 
Figure 13 Counter-regulatory hormone profiles during the experiments. Each group n=8. Data are means ± 
SE. *Significant difference from preoperative, P<0.02; #Significant difference by group, one symbol 




A strong negative correlation between mean cortisol and insulin stimulated WGD was 
seen in fasted (Fig. 14A), but not in CHO treated animals (Fig. 14B). 
 
Figure 14 Correlation between mean cortisol after surgery/control and the insulin stimulated increase in 
whole-body glucose disposal (i.e. peripheral insulin sensitivity) in fasted (A) and carbohydrate treated 
animals (B). Pearson’s correlation was used (n = 16). 
 
FFA concentrations were reduced in the CHO/surgery group compared to the 
fasting/surgery group both perioperatively and during the step-clamp procedures. 
Compared with the fasting/control group there was a similar, but statistically non-
significant (P=0.09) trend towards lower perioperative FFA in the CHO/control group, 
whereas no difference was seen during the step-clamps (Fig. 15). 
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Figure 15 Free fatty acid time course perioperatively (left) and during three step clamping (right) in the 
surgery (A) and control (B) groups. Each group n=8. Data are means ± SE. *Significantly different by 
group, one symbol P<0.05, Two symbols P<0.02 (two-way (time and group) repeated measures ANOVA) 
 
8.3. Paper III 
In paper III, we showed that skeletal muscle inflammatory responses to surgical trauma, 
as measured by the expression of IKKβ (Fig. 16A), SOCS3 (Fig. 16B) and ratio of 
phosphorylated to total JNK2 (Fig. 16C) were significantly lower in the CHO group than 
in the fasted group during the postoperative measurement of insulin. Further, the ratio of 
phosphorylated to total NFκB protein decreased in the CHO group during clamping 






Figure 16 Mean inhibitor κB kinase (IKKβ), suppressor of cytokine signaling 3 (SOCS3) and ratio of  
phosphorylated to total c-Jun N-terminal kinase 2 (JNK2) and nuclear factor kappa B (NFκB) protein 
expression presented as fold-change from preoperative values. Each group n=8. Data are means ± SE. 
*Significant difference by Mann Whitney U-test, #Significant difference by Wilcoxon t-test; one symbol, 
P<0.05; two symbols; P<0.02, three symbols; P<0.01, four symbols; P<0.001. 
 
Figure 17 Typical Western blots depicting 
IKKβ, SOCS3, JNK2 and NFκB protein bands 
with their corresponding molecular weights.  
Further, the inhibitory Ser307 phosphorylated IRS1 ratio was 2.4-fold reduced during 
clamping in the CHO group, whereas no significant change was seen in the fasting group 
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(Fig. 18A). A significant decrease in the ratio of inactivated FOXO1 to total FOXO1 was 
seen during clamping in the fasted group (-2.3-fold, P=0.05), but not in the CHO group (-
1.1-fold, P>0.05; Fig. 18B), demonstrating inhibitory action of insulin on FOXO1 in both 
groups, albeit to a greater extent in the preoperatively CHO treated animals. 
 
 
Figure 18 Mean ratio of Ser307 phosphorylated to 
total insulin receptor substrate 1 (IRS1, Fig. A) 
and Ser256 phosphorylated to total forkhead 
transcription factor 1 (FOXO1, Fig. B) presented 
as fold-change from preoperative values. Each 
group n=8. Data are means ± SE. *Significant 







Figure 19 Typical Western blots depicting IRS1 
and FOXO1 protein bands with their 






The restraining action of insulin on FOXO1 activity, i.e. ratio pFOXO1/tFOXO1 was 
confirmed by a strong correlation between the fold-change in phosphorylated to total 
Akt1 (i.e. activation) protein to fold-change phosphorylated to total FOXO1 (i.e. 
inactivation) protein from preoperative during insulin stimulation (Fig. 20).
  
Figure 20 The Pearson’s correlation between 
fold-change from preoperative levels in Ser473 
phosphorylated to total Akt1 and Ser256 
phosphorylated to total forkhead transcription 
factor 1 (FOXO1) in skeletal muscle during 
hyperinsulinaemic-euglycaemic clamping  
(n=16). 
 
The fold-change in ratio of phosphorylated to total FOXO1 during the clamp was 
significantly inversely correlated to the levels of PDK4 mRNA expression (Fig. 21). 
  
Figure 21 The Pearson’s correlation between 
pyruvate dehydrogenase kinase 4 (PDK4) gene 
expression and fold-change from preoperative 
levels in Ser256 phosphorylated to total forkhead 
transcription factor 1 (FOXO1) in skeletal 







Following surgery a similar ~20-fold 
increase in muscle PDK4 mRNA 
expression was seen in both groups (Fig. 
22A), whereas during the 4 hours of 
hyperinsulinaemic-euglycaemic 
clamping the inhibitory effect of insulin 
on muscle PDK4 mRNA expression in 
the CHO group was almost twice as 
great than in the fasting group compared 
to the postoperative values (Fig. 22B). 
Consequently, PDK4 protein expression 
measured during the clamp was almost 
5-fold lower in the CHO-loaded group 
than in the fasted group when compared 





Figure 22 Mean pyruvate dehydrogenase kinase 4 (PDK4) gene expression reported as fold-change from 
pre- and post-operative values and expression PDK4 protein reported as fold-change from preoperative. 
Each group n=8. Data are means ± SE. *Significant difference by Mann Whitney U-test, #Significant 




The rate of insulin 
stimulated whole-body 
glucose disposal was 
negatively correlated to 
both the level of muscle 
PDK4 protein 
expression and the ratio 
of phosphorylated to 
total NFκB (Figs. 23A 
and B, respectively). 
Furthermore, a strong 
positive relationship 
between PDK4 and 
p/tNFκB protein 
expression was observed 






Figure 23 Correlation between pyruvate dehydrogenase kinase 4 (PDK4) protein expression (A) and ratio 
of Ser536 phosphorylated to total NFκB (B) and whole-body glucose disposal rate during 
hyperinsulinaemic-euglycaemic clamping. Correlation between PDK4 and p/t NFκB during clamping is 
shown in C. Pearson’s correlation was used (n=16).
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8.4. Paper IV 
As in the immediate postoperative phase 
studied in paper II, a significant decrease 
in SS GIR at ~40 µU/ml serum insulin 
was measured on the 2nd day after 
surgery when compared to preoperative 
(11.19 ± 0.94 vs. 17.31 ± 1.53 
mg/kg/min, P<0.001). Significant 
postoperative reductions in WGD was 
seen during both low and high insulin 
clamps, whereas EGR remained 
unchanged, indicating isolated 
development of peripheral insulin 
resistance (Fig. 24).  
 
 Figure 24 Changes in EGR and WGD from 
basal during low (0.4 mU/mg/kg) and high (1.2 
mU/mg/kg) insulin clamps. Data are mean ± SE 
(n=8). *Significantly different from preoperative, 
one symbol P<0.01; two symbols P<0.002 
(Student’s dependent t-test).
Relative hyperglycaemia was seen on the 2nd postoperative day (5.68 ± 0.25 mmol/L vs. 
4.52 ± 0.42; P<0.05) and plasma FFA concentrations in conscious animals were also 
higher than before surgery, although this increase did not reach statistical significance 
(325 ± 48 vs. 236 ± 36 μmol/L, P=0.08). Arterial plasma FFA concentrations were 
unchanged during the basal period and were equally suppressed during low and high 
insulin clamping before and after surgery. During pyruvate-induced respiration, there was 
a postoperative reduction in Vmax of 61% in IFM and 40% in SSM with a modest 28% 
reduction of Voligo in SSM, but not IFM, whereas no postoperative change was seen 
























































































































































unchanged in SM mitochondria, while Voligo was increased in both SSM (1.9-fold) and 
IFM (2.5-fold) (Fig. 25). 
 
        A                          Glutamate 
 
       B                             Pyruvate 
 




Postoperatively, significant increases in the rates of H2O2 release from SSM (~2.3-fold), 
IFM (~2.5-fold) and liver mitochondria (~2.3-fold) were observed using glutamate as 
respiratory substrate (Fig. 26). 
 
Figure 26 Hydrogen peroxide (H2O2) production reported as fold-change from preoperative values in 
intermyofibrillar (IFM), subsarcolemmal (SSM) and liver mitochondria supplied with glutamate and malate 
as respiratory substrates. Data are mean ± SE of mitochondrial preparations from 7 pigs. *P<0.05 vs. 
preoperative (Student´s dependent t-test). 
When palmitoyl-L-carnitine was used as respiration substrate, O2·- release increased 
significantly after addition of GDP+ATR from both IFM and SSM, but not from liver 
mitochondria (Fig. 27).  
 
Figure 27 Pre- and postoperative % increase in relative fluorescence (RF) when superoxide (O2•-) release 
was estimated during Voligo palmitoyl-L-carnitine respiration after addition of GDP and ATR. Data are 
mean ± SE of mitochondrial preparations from 7 pigs. Significantly different vs. preoperative: *P<0.05, 
**P<0.01 (Student´s dependent t-test). 
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With PC as respiration substrate, ∆Vuncoupling after addition of GDP+ATR was slightly 
higher in the postoperative phase in both IFM (3.04 ± 0.52 vs. 7.31 ± 1.33 nmol 
























Various hyperinsulinaemic clamps, with or without glucose tracer infusion, have 
previously been applied in porcine experiments to examine different metabolic effects of 
insulin and only in a limited number of studies tracer enrichment was kept constant by 
either increased infusion rates during clamping or addition of tracer to the glucose 
infusate 164-166. Different species exhibit different basal glucose kinetics, insulin clearance 
rates and sensitivity 167,168 and of special importance, specific tracer glucose infusion 
rates are necessary to achieve adequate tracer enrichment levels. Owing to these issues 
and the relatively small amount and limited comparability of existing data, we sought to 
establish and test the step hot-GINF HEC technique and the possibility for combination 
with invasive investigative procedures before implementation in the following porcine 
studies on postoperative insulin resistance. 
In paper 1, substudy A, surgical instrumentation as described in 7.6.1. did not  
significantly alter circulating counter-regulatory hormone concentrations probably due to 
suppressive effects of anaesthesia on their release and/or that the surgical trauma was too 
limited to induce such a release. Further, basal insulin and C-peptide concentrations, 
glucose kinetics and glucose tracer atom percent enrichment were unaltered and thus, 
instrumentation needed for combination with invasive techniques such as organ-specific 
flowmetry and arterio-venous balance measurements can be accomplished without 
changing the labelling of the glucose infusates. Despite a relatively high maximal insulin 
infusion rate at 2.0 mU/kg/min in substudy B, relatively low serum insulin concentrations 
were achieved, probably due to the high rate of insulin clearance in pigs 168. However, 
this insulin concentration was sufficient to almost completely suppress EGR and elicit 
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peak metabolic efficiency in peripheral tissues, as demonstrated by the sigmoid shaped 
dose-response curve for WGD. Further, exogenous infusion of insulin completely 
diminished endogenous insulin secretion, demonstrated by C-peptide below detectable 
levels. Somewhat surprisingly, the insulin infusion rates selected on the basis of the dose-
response curves established in non-operated pigs in substudy B, resulted in substantially 
higher insulin serum concentrations during step-clamping in the operated pigs in 
substudy C. Because C-peptide levels were below detection level, the increase in insulin 
was probably caused by a decrease in insulin clearance. Metabolic insulin clearance 
during physiological hyperinsulinaemia is inseparably linked to insulin action, since 
binding to the insulin receptor constitutes the first step of degradation 169 and 
substantially decreased insulin clearance has been demonstrated in patients suffering 
from type 2 diabetes mellitus, obesity, and other conditions characterized by severe target 
cell insulin resistance 170,171. The liver represents the primary site of insulin clearance 
from endogenous release to the portal circulation by first-pass removal, whereas the 
kidneys remove the majority of insulin from the systemic circulation 169. Thus, as an 
alternative explanation, fluid shifts and relative hypovolemia with altered perfusion of 
these organs could have led to higher insulin levels postoperatively. However, the fact 
that continuous monitoring of heart rate and blood pressure as well as diuresis was not 
altered after surgery (data not shown) weighs against this explanation. An increase in 
circulating insulin similar to our study has been demonstrated during clamping in pigs 
with endotoxin-induced systemic inflammation without major effects on cardiovascular 
parameters 172. Further, metabolic insulin clearance has been reported to be increased in 
patients with multiple injuries 26, unchanged after severe scald injury in rats 173, and 
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decreased during hypovolemic shock in primates 174, indicating the possibility for both 
species and trauma variations.  
In paper II, the postoperative decline in overall (i.e. GIR) and peripheral  
insulin sensitivity (i.e. insulin-stimulated WGD) was reduced to statistically non-
significant levels by the single dose of CHO compared to fasting pigs. Importantly, the 
dose administered is similar to the amount given to patients and led to hyperglycaemia  
and a concomitant uniform rise in serum insulin corresponding to the levels seen after 
intake of low and rapid starch meals in pigs 175 and in human studies on preoperative 
CHO loading 140,163. Although a further effect of adding the evening CHO dose therefore 
seems unlikely it cannot, however be concluded that the evening dose is inefficient or 
unnecessary because our study did not include a group receiving a single evening dose or 
both doses of CHO.  
Because the postoperative decline in insulin-stimulated WGD was reduced,  
whereas EGR was not significantly affected by CHO, and no differences in liver and 
muscle glycogen content were found after surgery or during clamping, the improvement 
in postoperative insulin sensitivity in the CHO loaded group must have been caused by a 
higher level of oxidative glucose disposal in peripheral tissues. Skeletal muscle disposes 
~80% of glucose during euglycaemic insulin stimulation 176 and thus, the metabolic 
efficiency for glucose oxidation of skeletal muscle mitochondria after surgery must have 
been improved by preoperative CHO supplementation, which is in line with previous 
human studies 12,13. At least in part, this probably resulted from the reduction in peri- and 
postoperative plasma FFA levels and an attenuated metabolic competition from FFA on 
glucose oxidation through actions of the glucose-fatty acid cycle 177. In support of this 
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contention, mitochondrial oxidative metabolism of glucose during hyperinsulinaemic-
euglycaemic clamping is highly sensitive to the prevailing levels of FFA at the 
commencement of insulin stimulation 178. The fact that insulin sensitivity is markedly 
increased in fat cells after glucose ingestion due to increased insulin binding affinity 179 
could further explain the apparent reinforced antilipolytic effect of insulin infusion during 
clamping in the CHO group resulting in lower FFA.  
Cortisol, the cardinal driving force of acute insulin resistance and catabolism, was  
increased after surgery independently of preoperative CHO supplementation. However, 
the strong negative correlation between cortisol and insulin-mediated glucose disposal in 
the fasted animals was lessened by CHO administration, indicating that 
hyperinsulinaemia in response to CHO administration immediately prior to surgery 
antagonizes the acute restraining actions of cortisol on glucose oxidation in skeletal 
muscle through regulation of PDK4 expression (Section 5.7.). As previously described, 
muscle PDK4 expression in humans was reduced by a preoperative oral nutritional 
supplement drink 142 and the authors speculated that this was related to a reduction in 
plasma FFA concentrations, possibly through subsequent reduction in PPARα -mediated 
PDK4 expression 180, because no effect on FOXO1 activity was seen. Of note, PPAR 
activity was not measured in paper III. However, the suppressive effect of insulin on 
PDK4 mRNA expression in skeletal muscle is independent of its restraining effect on 
plasma FFA 98, which weighs against the role of PPAR signalling. 
Intriguingly, preoperative CHO treatment has recently been shown to significantly  
reduce circulating IL-6 levels until the 3rd postoperative day after major abdominal 
surgery 20, and multivariate analysis led to the hypothesis that modulation of the 
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inflammatory response to surgery was of key importance to the attenuation of 
postoperative insulin resistance. In support of this contention physiological levels of 
insulin exhibits potent and fast inhibition of NFкB in mononuclear cells 181 and reduces 
the expression of pro-inflammatory cytokines in endotoxemic human macrophages 182. 
Further, subcutaneous administration of insulin in a dosage with minimal or no effect on 
glucose levels has been shown to attenuate the hepatic and systemic inflammatory 
response in a dose dependent manner 183 and increase the anti-inflammatory response to 
endotoxemia 184 and thermal trauma in rodents 183. In pigs, plasma TNFα and IL-6 
concentrations in response to lipopolysaccharide infusion-induced systemic inflammation 
are reduced if the lipopolysaccharide infusion is preceded by a low-dose 
hyperinsulinaemic-euglycaemic clamp 172. Thus, the cause of the blunted systemic 
inflammatory response in this human study 20 was probably not directly related to the 
CHO load itself, but rather was a result of anti-inflammatory properties of the concurrent 
preoperative hyperinsulinaemia. 
On this basis, in paper III we utilized biopsies harvested during the experiments in  
the surgery groups in paper II to test the hypothesis that CHO attenuates postoperative 
insulin resistance via reduction of the inflammatory response and inhibition of insulin 
signal transduction in skeletal muscle, thereby improving the restraining effects of insulin 
on FOXO1-mediated PDK4 expression. The primary finding in paper III was the ~5-fold 
lower expression of PDK4 protein in the CHO group than in the fasted group (Fig. 22C) 
during clamping, which could have accounted for the improvement in postoperative 
peripheral glucose disposal in this group. Although CHO administration did not 
significantly attenuate the increase in PDK4 gene expression after surgery compared with 
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the fasting group, it did lead to improved insulin-mediated regulation of PDK4 mRNA 
during clamping. The reduced ratio of inhibitory Ser307 phosphorylated to total IRS1 (Fig. 
18A) was probably an important underlying factor to the improvement in the downstream 
IRS1 signalling in the CHO group during the clamp as reflected by the lower fall of the 
phosphorylated (inactive) to total ratio of FOXO1 and by stronger inhibitory drive of 
insulin through the IRS1-Akt1-FOXO1 pathway on PDK4 mRNA and protein expression 
compared with the fasted group (Figs. 18, 20 and 22). The apparent improvement in 
postoperative insulin signalling in the CHO group could be explained by the lower 
expression of muscle IKKβ, JNK2 and SOCS3, all known for their ability to negatively 
interact with IRS1 185. The notion that local expression of inflammatory mediators may 
contribute to activation of the cellular mechanisms that induce acute insulin resistance in 
skeletal muscle after surgery and that preoperative CHO supplementation modulates this 
inflammatory response is further supported by the observation that NFкB activity was 
reduced in the CHO loaded group when compared with the preoperative levels, and 
correlated significantly inversely with peripheral insulin sensitivity during clamping and 
directly with PDK4 protein expression. Further, the fact that no difference in peripheral 
insulin sensitivity during clamping was seen between the CHO treated and fasted control 
groups in paper II weighs against the previously suggested role of facilitated glucose 
disposal (Staub-Traugott effect) 145 and supports the notion that the improvement in 
glucose disposal after preoperative CHO administration is prophylactic by nature and 
limited to surgically stressed individuals. The proposed underlying mechanism of the 





Figure 28 Proposed mechanism underlying the prophylactic effect of preoperative carbohydrate loading 
(CHO) on inflammatory interference with insulin regulation of pyruvate dehydrogenase kinase 4 (PDK4) 
expression in muscle after surgery. 
  A: PDK4 expression in muscle is increased after surgery both by a cortisol-induced increase in 
transcription and reduced insulin-mediated inhibitory phosphorylation (pSer256) of forkhead transcription 
factor 1 (FOXO1), which increases the PDK4 gene responsiveness to glucocorticoids. Insulin action is 
inhibited by the serine/threonine kinases inhibitor κB kinase (IKKβ) and c-Jun N-terminal kinase (JNK) 
which are activated by cytokines after surgery, resulting in inhibitory phosphorylation (pSer307) of insulin 
receptor substrate 1 (IRS1) and impaired downstream propagation of insulin signalling. IKKβ and JNK also 
induce expression of suppressor of cytokine signalling 3 (SOCS3) which targets IRS1 for degradation.  
B: CHO improves insulin-mediated inhibitory phosphorylation of FoxO1 and regulation of PDK4  
expression in muscle after surgery by reducing postoperative IKKβ, JNK and inhibitory phosphorylation of 
IRS1. We propose that these effects occur due to anti-inflammatory properties of hyperinsulinaemia 
following CHO administration in the immediate preoperative phase.     /   and     /   arrows indicate 
upregulation/increased activity and downregulation/decreased activity, while arrow thickness indicates the 
magnitude of the effect. 
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In paper IV, we found that on the 2nd day after major open abdominal surgery (albeit 
somewhat different than in paper II/III), postoperative insulin resistance was still located 
in peripheral tissues (i.e. skeletal muscle) and developed along with relative 
hyperglycaemia, a trend toward higher circulating FFA concentrations and a severe 
impairment in the capacity of pyruvate oxidation (i.e. Vmax) in skeletal muscle 
mitochondria. When glutamate was used as an alternative complex I substrate, which is 
thought to yield fairly identical respiration conditions as pyruvate 186, but is transported 
across the mitochondrial membrane by the electroneutral glutamate/OH exchanger and is 
oxidized by glutamate dehydrogenase to feed the tricarboxylic acid cycle, the 
postoperative maximal oxidative capacity was unchanged. The same observation was 
made for the Vmax for palmitoyl-L-carnitine (PC), which feeds the electron transport 
chain through β-oxidation. This strongly indicates that the reduction in pyruvate 
oxidation is due to a reduced capacity of PDC rather than overall impairment in the 
mitochondrial tricarboxylic acid cycle and/or electron transport chain and further 
supports the involvement of PDK4, as suggested by the findings in paper III. Importantly, 
PDK4 up-regulation is expected to affect pyruvate oxidation in isolated mitochondria, as 
the protein is located within the mitochondrial matrix. However, our results are weakened 
by the lack of PDK4 expression and/or PDC enzyme activity measurements in paper IV. 
Increased FFA availability could also lead to a reduction of pyruvate flux into the 
mitochondria by actions of the glucose-fatty acid cycle. In this regard the current increase 
in plasma FFA after surgery, although not statistically significant, could have contributed 
to our findings. 
To our knowledge, we are the first to assess liver and skeletal muscle  
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mitochondrial ROS release in a surgery-induced acute insulin resistant setting. This was 
done by direct measurement of ROS species during respiration with glutamate, a 
substrate which, in an experimental context, is known to induce fairly low, but 
physiological levels of ROS 187. Our results indicate that the potential for ROS release 
from the electron transport chain complexes in skeletal muscle and liver mitochondria is 
increased after surgical trauma, which could play a role in the development of 
postoperative insulin resistance (Section 5.9.). In contrary to what we expected, such an 
increase was not evident when the rate of O2·- release was measured. However, this can 
be attributed to sufficient scavenging of O2·- by superoxide dismutase and similar 
scavengers, with a subsequent increase in H2O2 levels.  
To estimate the level of uncoupling, leak oxygen consumption was measured by  
blocking the ATP synthase and inhibition of the most essential mitochondrial uncouplers 
uncoupling protein 2/3 and adenine nucleotide translocase 188. While no changes were 
observed with glutamate or pyruvate, there was significantly increased leak oxygen 
consumption in skeletal muscle mitochondria respiring on PC, indicating FFA-dependent 
activation of uncoupling. This finding is supported by evidence that the presence of FFA 
derivatives is necessary for complete induction of uncoupling through a synergistic co-
activation with ROS species 189,190. Surprisingly, the postoperative increase in Voligo was 
only slightly lowered when exposing mitochondria to ATR and GDP. However, the 
severe increase in the levels of O2·- release after addition of GDP and ATR indicates that 
uncoupling was activated leading to higher rates of ROS elimination after surgery. Why 
this was not reflected by a reversal of mitochondrial leak respiration to preoperative 
levels when ATR and GDP was added is not clear to us, as we would have expected any 
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increase in Voligo to be almost completely eliminated by uncoupling inhibitors. Possible 
reasons for this could either be a lack of specificity of ATR and GDP 191-193 and thereby 
only partial inhibition of uncoupling, or increased leak respiration due to proton leakage 
through mitochondrial membrane proteins other than UCPs and ANT.  
Collectively, the results in paper IV show that alterations in physiological  
properties of mitochondria in insulin sensitive tissues, similar to those previously 
demonstrated in chronic insulin resistant states develop along with surgery-induced acute 
insulin resistance in skeletal muscle, although the causal relationship between these 

















10. GENERAL CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
A few concluding remarks on the research model are warranted when interpreting the 
results of our studies. The healthy, young, growing pigs studied in this experimental work 
may not represent a perfect imitation of the mostly adult and sometimes multimorbid 
human patient, although the use of swine as a model for biomedical research is 
considered as close to human as possible due to the nutritional, metabolic and 
physiological resemblance. However, it should be noted that whereas de novo fatty acid 
synthesis is mainly located in the human liver, glucose and other carbon precursors are 
incorporated readily into fatty acids in swine adipose tissue, which is the major site for de 
novo synthesis in pigs 64.  
FFA concentrations during clamping were considerably higher in paper I than  
paper II. A causal explanation cannot be found in the plasma levels of catecholamines, 
which were equal in the two studies. However, differences in blood sample handling, 
amount of added lipase inhibitor to the sample vials, in the performance of FFA analyses, 
or colorimetric assay kit and microplate reader variability cannot be excluded. 
Higher cortisol levels were seen in the two control groups in paper II than in the  
surgically untouched pigs in substudy B, paper I. This could be explained by surgical 
stress related to the mini-laparotomy and serial muscle and liver biopsy sampling in paper 
II.  
Since the animal experiments were performed during continuous anaesthesia one  
should take note of the fact that several anaesthetic agents possess the ability of 
modifying the hormonal and metabolic responses to surgery, including those currently 
used. A reduction in cortisol levels and blood glucose during and immediate after surgery 
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can be achieved by addition of fentanyl to the anaesthetic regime 194. The effect is also 
seen in pigs 195, is dose dependent 196 and, importantly, requires administration of 
fentanyl prior to the onset of surgery 197. Induction of anaesthesia with midazolam 
followed by continuous infusion during upper abdominal surgery has been shown to 
delay the increase in circulating cortisol and glucose, and to reduce intraoperative levels 
of insulin 198. In addition midazolam has been shown to attenuate the perioperative 
increase in plasma epinephrine levels 199. Inhalational agents, including isoflurane, impair 
insulin secretion and glucose utilization following intravenous glucose administration 
200,201  and has been shown to increase blood glucose shortly after induction of 
anaesthesia 202. In contrast to the effects of fentanyl and midazolam, the stress hormone 
response to surgery is not significantly affected by anaesthesia with isoflurane 203,204. 
Furthermore, several anaesthetic agents have suppressive effects on mitochondrial 
electron flow and oxidative phosphorylation capacity 117. 
The apparent anti-inflammatory response in muscle tissue to preoperative CHO  
supplementation in our study could, at least in part, have been counteracted by pro-
inflammatory effects of glucose ingestion in mononuclear cells, as previously reported in 
healthy humans 205. Interestingly, addition of an insulinotropic amino acid and protein 
mixture to a CHO beverage increases the plasma insulin response by up to 100%  without 
increasing hyperglycaemia 206 and it has been shown that patients receiving preoperative 
CHO in combination with milk whey protein exhibit reduced acute phase response after 
moderate sized surgery 207. Furthermore, the prophylactic effect of preoperative CHO 
loading on postoperative insulin resistance in colorectal surgery patients was improved 
by early postoperative intake of a polymeric nutritional supplement containing fat, 
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protein and carbohydrates 208. In this regard, and with the results of the current thesis in 
mind, nutrient activation of the so-called anti-inflammatory neuro-immune pathway, a 
“hard-wired” neural system constituted by the afferent and efferent arc of the vagus nerve 
209, represents a possible link between perioperative feeding and modulation of the 
systemic inflammatory response to surgical trauma. Efferent vagus nerve activity 
mediates acetylcholine release in organs containing tissue macrophages belonging to the 
reticuloendothelial system, such as the liver, spleen, heart and gastrointestinal tract 209. 
Acetylcholine inhibits transcription and release of pro-inflammatory cytokines from these 
macrophages through activation of the nicotinic acetylcholine receptor subunit α7, which 
is thought to decrease the set point of the innate immune response relative to a given 
injury stimulus 210. Most intriguingly, recent murine and human experiments have shown 
that gastrointestinal hormones, including cholecystokinin and glucagon-like peptide 1 
secreted from enteroendocrine cells upon absorption of macronutrients trigger the anti-
inflammatory pathway through afferent vagus signalling, leading to reduced systemic 
inflammatory response to endotoxaemia and surgical bowel manipulation 211-213. 
Thus, this thesis introduces an experimental model which can be extended with  
further interventions and modified with additional metabolic tracers, inter-organ blood 
sampling and flow measurements to investigate the metabolic and cellular effects of more 
complex formulated oral perioperative supplements eventually leading to new clinical 








11. MAIN CONCLUSIONS 
 
1. Step hot-GINF HEC is a feasible technique and seems well suited for porcine 
research models on acute insulin resistance, but attention must be paid to 
alterations in circulating insulin. Combination with invasive research techniques 
requiring extensive surgical instrumentation can be accomplished without the 
premises for utilization of the technique being altered. 
 
2. Single-dose preoperative oral carbohydrate supplementation two hours prior to 
surgery is sufficient to reduce development of peripheral insulin resistance and 
maintain oxidative glucose disposal immediately after major surgery in pigs.  
 
 
3. The postoperative improvement in glucose disposal is prophylactic by nature and 
seems to be limited to surgically stressed animals by antilipolytic effects and 
antagonist properties of preoperative hyperinsulinaemia on the suppressant 
actions of cortisol on carbohydrate oxidation. 
 
4. Oral carbohydrate administration in the immediate preoperative phase reduces the 
skeletal muscle inflammatory response to surgical trauma, the interference of 
inflammatory mediators with insulin downstream signal transduction, and 
improves the ability of insulin to suppress FOXO1-mediated PDK4 expression in 
skeletal muscle after surgery. This could, at least in part, explain the prophylactic 




5. In line with the molecular data, isolated impairment in skeletal muscle 
mitochondrial pyruvate oxidation capacity develops along with peripheral insulin 
resistance in the postoperative phase after major abdominal surgery.  
 
6. Mitochondrial ROS release is increased in both skeletal muscle and liver after 
surgery, whereas mitochondria from skeletal muscle exhibit increased fatty acid-
induced uncoupling. The causal relationship between these changes and the 





















Paper I:  
• The expression “insulin unresponsiveness” should replace “insulin 
insensitivity” and vice versa throughout the paper.   
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